The Role of MRI Lesions in Identifying Secondary Progressive Multiple Sclerosis: A Comprehensive Review
- PMID: 40565860
- PMCID: PMC12194792
- DOI: 10.3390/jcm14124114
The Role of MRI Lesions in Identifying Secondary Progressive Multiple Sclerosis: A Comprehensive Review
Abstract
Secondary Progressive Multiple Sclerosis (SPMS) represents a challenging phase of multiple sclerosis, marked by gradual neurological decline and reduced inflammatory activity. In recent years, magnetic resonance imaging (MRI) has become essential for characterizing the neurodegenerative changes underlying SPMS, including white and gray matter damage, brain atrophy, slowly expanding lesions, and iron rim lesions. This narrative review aims to synthesize the current knowledge on established and emerging MRI biomarkers relevant to SPMS, with a particular focus on their diagnostic, prognostic, and therapeutic implications. This review discusses key themes, such as the shift from inflammatory to neurodegenerative mechanisms, the role of advanced imaging techniques, and the limitations of conventional MRI in detecting smoldering disease. In doing so, it identifies current gaps in evidence, including the need for standardized imaging protocols and large-scale longitudinal studies. A clearer understanding and application of MRI biomarkers may facilitate earlier diagnosis, more tailored treatment strategies, and improved outcomes in patients with SPMS.
Keywords: MRI lesions; gray matter atrophy; iron rim lesions; secondary progressive multiple sclerosis; slowly expanding lesions; spinal cord lesions.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Siponimod for multiple sclerosis.Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013647. doi: 10.1002/14651858.CD013647.pub2. Cochrane Database Syst Rev. 2021. PMID: 34783010 Free PMC article.
-
Interferon beta for secondary progressive multiple sclerosis.Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD005181. doi: 10.1002/14651858.CD005181.pub3. Cochrane Database Syst Rev. 2012. PMID: 22258960 Free PMC article.
-
Cladribine tablets in the new multiple sclerosis era.Ther Adv Neurol Disord. 2025 Jun 19;18:17562864251342855. doi: 10.1177/17562864251342855. eCollection 2025. Ther Adv Neurol Disord. 2025. PMID: 40547863 Free PMC article. Review.
-
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.J Psychiatr Ment Health Nurs. 2024 Aug;31(4):681-698. doi: 10.1111/jpm.13023. Epub 2024 Jan 17. J Psychiatr Ment Health Nurs. 2024. PMID: 38230967
-
Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.Neuroimage Clin. 2015 Dec 4;10:192-238. doi: 10.1016/j.nicl.2015.11.019. eCollection 2016. Neuroimage Clin. 2015. PMID: 26862478 Free PMC article.
References
-
- Ciubotaru A., Alexa D., Grosu C., Böckels L., Păvăleanu I., Maștaleru A., Leon M.M., Covali R., Roman E.M., Bistriceanu C.E., et al. Validation of a Set of Clinical Criteria for the Diagnosis of Secondary Progressive Multiple Sclerosis. Brain Sci. 2024;14:1141. doi: 10.3390/brainsci14111141. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources